DK147591C - Doseringsenhed til kontrolleret afgivelse af et terapeutisk aktivt stof - Google Patents

Doseringsenhed til kontrolleret afgivelse af et terapeutisk aktivt stof

Info

Publication number
DK147591C
DK147591C DK137878A DK137878A DK147591C DK 147591 C DK147591 C DK 147591C DK 137878 A DK137878 A DK 137878A DK 137878 A DK137878 A DK 137878A DK 147591 C DK147591 C DK 147591C
Authority
DK
Denmark
Prior art keywords
active substance
dosage unit
controlled delivery
therapeutic active
therapeutic
Prior art date
Application number
DK137878A
Other languages
English (en)
Other versions
DK147591B (da
DK137878A (da
Inventor
Helle Bechgaard
Arne Martinus Pedersen
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Publication of DK137878A publication Critical patent/DK137878A/da
Publication of DK147591B publication Critical patent/DK147591B/da
Application granted granted Critical
Publication of DK147591C publication Critical patent/DK147591C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK137878A 1977-03-30 1978-03-29 Doseringsenhed til kontrolleret afgivelse af et terapeutisk aktivt stof DK147591C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1329677 1977-03-30
GB13296/77A GB1576376A (en) 1977-03-30 1977-03-30 Multiple-unit drug dose

Publications (3)

Publication Number Publication Date
DK137878A DK137878A (da) 1978-10-01
DK147591B DK147591B (da) 1984-10-15
DK147591C true DK147591C (da) 1985-07-15

Family

ID=10020381

Family Applications (1)

Application Number Title Priority Date Filing Date
DK137878A DK147591C (da) 1977-03-30 1978-03-29 Doseringsenhed til kontrolleret afgivelse af et terapeutisk aktivt stof

Country Status (12)

Country Link
US (1) US4193985A (da)
BE (1) BE865451A (da)
CH (1) CH629956A5 (da)
DE (1) DE2813480C2 (da)
DK (1) DK147591C (da)
FI (1) FI69564C (da)
FR (1) FR2395026A1 (da)
GB (1) GB1576376A (da)
LU (1) LU79333A1 (da)
NL (1) NL189747C (da)
NO (1) NO149376C (da)
SE (1) SE432193B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4339428A (en) * 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
JPS59500614A (ja) * 1982-04-23 1984-04-12 エイ／エス　アルフレツド　ベンツオン 消化機能調査用の組成物と方法
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE59287B1 (en) 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3431861A1 (de) * 1984-08-30 1986-03-13 Troponwerke GmbH & Co KG, 5000 Köln Pellet-zubereitung
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629620A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4976949A (en) * 1985-10-25 1990-12-11 The University Of Michigan Controlled release dosage form
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
DE3622487A1 (de) * 1986-07-02 1988-01-14 Schering Ag Arzneimittel mit verzoegerter wirkstoffabgabe
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
ATE71293T1 (de) * 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
NZ234227A (en) * 1989-06-30 1991-08-27 Smithkline Beecham Corp Delayed release dosage form
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
US6558708B1 (en) 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
US7939522B1 (en) 1998-11-23 2011-05-10 Bonnie M Davis Dosage formulations for acetylcholinesterase inhibitors
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
BR112014024159A2 (pt) 2012-03-29 2017-06-20 Therabiome Llc Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice.
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
WO2019223753A1 (zh) 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释***及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
CN113975413A (zh) * 2021-11-10 2022-01-28 博迈医疗科技(常州)有限公司 一种胃肠动力标记物及其制备方法、胃肠动力标记物胶囊

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801203A (en) * 1951-03-22 1957-07-30 Byk Gulden Lomberg Chem Fab X-ray method of digestive enzyme diagnosis using protected core of contrast agent
CA614091A (en) * 1956-11-05 1961-02-07 Commonwealth Scientific And Industrial Research Organization Time delay pill for ruminant
US3017329A (en) * 1957-08-15 1962-01-16 Dow Chemical Co Method of locating enteric constrictions with a plurality of pills containing an x-ray contrast agent
DK106457C (da) * 1962-01-23 1967-02-06 Ernst Helmer Hagstam Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling.
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3341417A (en) * 1965-07-14 1967-09-12 Edwin S Sinaiko Method of and means for diagnosis of ingested drugs with radio-opaque and other indicators
JPS4427839B1 (da) * 1966-04-18 1969-11-18
US3592185A (en) * 1967-04-18 1971-07-13 Yeda Res & Dev Ferromagnetic contrast media and method of use
US3608061A (en) * 1968-08-21 1971-09-21 Edmund F Mcnally Radiopaque esophageal marshmallow bolus
JPS4824246B1 (da) * 1969-03-20 1973-07-19
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
CA972288A (en) * 1971-01-20 1975-08-05 Gyorgy Hajos Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity
FR2183546B1 (da) * 1972-05-10 1975-06-20 Servier Lab
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations

Also Published As

Publication number Publication date
FR2395026A1 (fr) 1979-01-19
GB1576376A (en) 1980-10-08
NO149376C (no) 1984-04-11
FR2395026B1 (da) 1981-07-24
BE865451A (fr) 1978-07-17
DE2813480A1 (de) 1978-10-05
CH629956A5 (fr) 1982-05-28
LU79333A1 (fr) 1978-07-13
NL189747C (nl) 1993-07-16
SE432193B (sv) 1984-03-26
SE7803527L (sv) 1978-10-01
DK147591B (da) 1984-10-15
FI69564B (fi) 1985-11-29
US4193985A (en) 1980-03-18
DK137878A (da) 1978-10-01
NL7803309A (nl) 1978-10-03
FI780955A (fi) 1978-10-01
NO781079L (no) 1978-10-03
FI69564C (fi) 1986-03-10
DE2813480C2 (de) 1986-09-25
NO149376B (no) 1984-01-02

Similar Documents

Publication Publication Date Title
DK147591C (da) Doseringsenhed til kontrolleret afgivelse af et terapeutisk aktivt stof
SE7805954L (sv) Terapeutiska medel
SE7804890L (sv) Anordning for utmatning av lekemedel
DK236178A (da) Praeparat indbefattende et pulveriseret renset stof vand og dispergeringsmiddel samt fremgangsmaade til fremstilling af et saadant praeparat
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO151240C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler
DK148344C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof
BE879918A (fr) Distributeur de medicament
DK153773C (da) Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel
DK524080A (da) Farmaceutiske midler indeholdende et kortikosteroidt stof
DK154329C (da) Apparat til inhalation af pulverformige laegemidler
DK499183D0 (da) Faste doseringsformer med konstant virkning ved en ikke-ensartet fordeling af aktivt stof
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
DK251878A (da) Indretning til kutan indgiftaf medicin
SE7802499L (sv) Anordning for doserad avgivning av en vetska
IT1114247B (it) Componente di dosaggio farmaceutico a emissione controllata
SE7601894L (sv) Terapeutiskt medel
SE7809887L (sv) Terapeutiska medel
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
SE424982B (sv) Anordning for dosering av virke
DK313281A (da) Anordning til indgift af medicinsk aktive substanser
DK314978A (da) Psykofarmakologiske peptider til terapeutisk administration
NL7802938A (nl) Nieuw therapeutisch preparaat met trans- -broparestrol als actieve stof.
SE425181B (sv) Anordning for styrning av en doserpump
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere